In this interview, Medi Sadagian, Associate Principal Scientist at DSM-Firmenich, provides a comprehensive overview of postbiotics and their growing relevance for the dietary supplement and pharmaceutical industries. Focusing on Humiome® Post LB, he clarifies how postbiotics differ from pro and prebiotics, highlighting their unique mechanism of action, strong clinical evidence in digestive health, and emerging research on the gut–brain axis.
Postbiotics: the story, the evidences, the ingredient
How postbiotics are reshaping dietary supplements and pharma: key insights from Humiome® Post LB.
dsm-firmenich is a global leader in science-backed health, nutrition, and biosciences. Beyond traditional vitamins, the company is driving innovation with Biotic Vitamins, Human Milk Oligosaccharides ...
dsm-firmenich is part of
More from Company dsm-firmenich
Gastroenterology
Latest News
Video, Gastroenterology
Gastroenterology
Gastroenterology
Scientific research